home > products > product list > ulceranin tab, inj

Ulceranin tab, inj

Category
Gastrointestinal & Hepatobiliary System – Antacid/Anti Ulcerant

 

Composition

Each film coated tablet contains : Ranitidine 150 mg

Ulceranin Injection contains : Ranitidine 50 mg/ 2 ml

 

Indication

Treatment of pathological hypersecretory conditions (e.g, Zollinger-Ellison syndrome and systemic mastocytosis),  gastric ulcer, duodenal ulcer, reflux of esophagitis.

 

Recommended Dosage

Tablet (Adult)

Duodenal ulcer : 150 mg twice daily for 4 weeks. Gastric ulcer : 150 mg twice daily for 2 weeks. Reflux of esophagitis : 150 mg twice daily.

Pathological hypersecretory conditions : 150 mg twice daily, may be increased to 900 mg.

Patients with impaired renal function (Creatinine Clearance < 50 mL/min) : 150 mg daily, may be increased to 300 mg.

Ampoule (Adult)

Intermittent infusion : 50 mg diluted to 100 ml. Intermittent bolus : 50 mg diluted to 20 ml every 6 - 8 hours.

IM : 50 mg (without dilution) every 6 - 8 hours

 

 

 

see also Ranitidin Inj [Generic]

Overview

Considering the vast market potential, Otto is setting up a new formulation facility for manufacturing Tablets, Capsules, Syrup,...

read more

Research & Development

OTTO is aware of the importance of research and development in the pharmaceutical industry...

read more